FMR LLC 13D/13G Filings for TG Therapeutics, Inc. (TGTX)

FMR LLC 13D and 13G filings for TG Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2023-02-09
12:39 pm
Sale		2023-02-0913GTG Therapeutics, Inc.
TGTX		FMR LLC7,188,862
4.946%		-865,599decrease
(-10.75%)		Filing
2022-07-11
08:49 am
Sale		2022-07-0813GTG Therapeutics, Inc.
TGTX		FMR LLC8,054,461
5.576%		-12,666,970decrease
(-61.13%)		Filing
2022-02-09
10:01 am
Purchase		2022-02-0813GTG Therapeutics, Inc.
TGTX		FMR LLC20,721,431
14.496%		5,894,295increase
(+39.75%)		Filing
2021-02-08
10:33 am
Purchase		2021-02-0513GTG Therapeutics, Inc.
TGTX		FMR LLC14,827,136
10.963%		2,179,411increase
(+17.23%)		Filing